查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1405914

美國體外診斷市場規模、佔有率、趨勢分析報告：按產品、技術、應用、最終用途、細分市場預測，2024-2030

U.S. In Vitro Diagnostics Market Size, Share & Trends Analysis Report By Product (Reagents, Instruments, Services), By Technology (Immunoassay, Molecular Diagnostics), By Application, By End-use, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 358 Pages | 商品交期: 2-10個工作天內

價格

美國IVD 市場成長與趨勢：

Grand View Research, Inc.的最新報告顯示，到2030年，美國體外診斷市場規模預計將達到375.8億美元。

預計2024年至2030年該市場將以3.70%的複合年成長率成長。對血液、尿液和組織等生物液體進行診斷測試的醫療設備稱為體外診斷 (IVD)。 IVD 測試用於藥物治療研究以及感染疾病、自體免疫疾病和各種醫療狀況的識別和評估。

慢性病和致病性疾病盛行率的上升、人口高齡化、即時檢測的普及以及個人化醫療預計將增加該國體外診斷藥物（IVD）檢測的需求。此外，隨著基因組學和蛋白​​質組學的進步，隨著分子診斷擴大其範圍並引入各種新的病理特異性指標和測試，該行業正在尋找新的視野。

有些疾病變得越來越常見，包括遺傳、心血管和神經系統疾病。據美國疾病管制與預防中心 (CDC) 稱，心血管疾病 (CVD) 是美國的首要死因，每年估計有 659,000 人死亡。因此，大眾早期診斷意識不斷增強，常規診斷不斷增強，這兩者都支撐著整個市場的發展。

先進體外診斷藥物的推出正在推動市場快速擴張。此外，市場參與企業和研究機構正在積極致力於開發新產品，以減輕該國的整體疾病負擔。例如，2021年5月，加州大學開發了一種超靈敏的分子測試。該測試基於晶片技術，可以檢測甲型流感和SARS-CoV-2抗原的存在。進一步的研究正在進行中，旨在將該測試轉化為 PoC（照護端）測試。

即時檢測機構採用 IVD 檢測的情況正在迅速增加。隨著多家公司專注於推出居家照護設施的測試，該行業的動態正在改變。此外，2021年，FDA也優先考慮了家庭分子診斷測試。 2021 年 3 月，BATM Advanced Communications Limited 宣布推出用於檢測 COVID-19 的分子診斷自檢檢測套組。

隨著診斷實驗室採用全自動工具，這個市場正在增強。與手動或半自動化設備相比，自動化設備具有高度擴充性，滿足高性能，減少實驗室技術人員的時間，消除批量測試，並為醫生提供更快的結果。由於這些優勢，市場參與企業擴大建造自動化設備。

此外，實驗室自動化促進、加速並提高了診斷測試的效率和有效性。從裝載檢體管到為所有主要測試區域提供觀察，綜合實驗室自動化系統可以處理測試過程的每個部分。隨著越來越多的製造商以更廣泛的自動化選項進入市場，臨床診斷業務中實驗室自動化的發展不斷加速。

COVID-19 大流行增加了對分子診斷工具的需求，因為它們已被用來檢測 SARS-CoV-2 病毒。此外，住院的 COVID-19 患者對測量血糖值、肌鈣蛋白和各種其他參數的檢測套組和用品的需求激增。因此，在大流行期間體外診斷的使用增加，推動了市場成長。

美國體外診斷市場報告亮點

  • 從產品來看，由於美國對基因檢測的需求不斷成長以及先進癌症診斷測試​​的可用性，試劑產業在美國體外診斷市場中佔有很大佔有率。
  • 混凝行業預計將快速成長。心血管疾病、血液相關疾病和自體免疫疾病盛行率的上升預計將推動對血液凝固檢驗的需求。
  • 由於患病率上升以及人們對該疾病早期診斷的認知不斷提高，預計癌症行業在預測期內將以最快的複合年成長率成長。
  • 主要市場參與企業包括 QIAGEN、F. Hoffman-La Roche Ltd.、Thermo Fisher Scientific, Inc.、Danaher Corporation 和 Illumina。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章美國IVD 市場變數、趨勢與範圍

  • 體外診斷市場前景
    • 母市場展望
  • 法律規範
  • 市場促進因素分析
    • 老年人口增加
    • 技術進步
    • 對 POC 設施的需求增加
    • 遺傳疾病、心血管疾病、神經系統疾病、醫院感染等目標疾病盛行率上升
    • 新型冠狀病毒感染疾病（COVID-19）的爆發
  • 市場抑制因素分析
    • 設備成本較高
    • 嚴格的監理政策
  • 價值鏈分析
    • 價值鏈分析/市場路徑
  • SWOT 分析，按因素（政治/法律、經濟、技術）
  • 波特五力分析

第4章美國IVD 市場 - 按產品細分分析，2018-2030

  • 美國體外診斷市場：產品波動分析
  • 裝置
    • 2018-2030 年設備市場估計與預測
  • 試劑
    • 2018-2030 年試劑市場估計與預測
  • 服務
    • 2018-2030 年服務市場估計與預測

第5章 2018-2030 年美國IVD 市場細分分析（依技術）

  • 體外診斷市場：技術變革分析
  • 免疫檢測
    • 2018-2030 年免疫檢測市場估計與預測
    • 裝置
    • 試劑
    • 服務
  • 血液學
    • 2018-2030 年血液學市場估計與預測
    • 裝置
    • 試劑
    • 服務
  • 臨床化學
    • 2018-2030 年臨床化學市場估計與預測
    • 裝置
    • 試劑
    • 服務
  • 分子診斷
    • 2018-2030 年分子診斷市場估計與預測
    • 裝置
    • 試劑
    • 服務
  • 凝固
    • 2018-2030 年混凝市場估計與預測
    • 裝置
    • 試劑
    • 服務
  • 微生物學
    • 微生物學市場估計與預測，2018-2030
    • 裝置
    • 試劑
    • 服務
  • 其他
    • 2018-2030 年其他市場估計與預測
    • 裝置
    • 試劑
    • 服務

第6章美國IVD 市場：細分分析，依最終用途，2018-2030 年

  • 體外診斷市場：最終用途變異分析
  • 醫院
    • 2018-2030 年醫院市場估計與預測
    • 按技術分類的醫院市場
  • 實驗室
    • 2018-2030 年實驗室市場估計與預測
    • 實驗室市場（按技術）
  • 居家護理
    • 2018-2030 年家庭護理市場估計與預測
    • 按科技分類的居家照護市場
  • 其他
    • 2018-2030 年其他市場估計與預測
    • 其他市場，依技術分類

第 7 章美國IVD 市場：2018-2030 年按應用細分分析

  • 美國體外診斷市場：應用變化分析
  • 感染疾病
    • 2018-2030 年感染疾病市場估計與預測
  • 糖尿病
    • 2018-2030 年糖尿病市場估計與預測
  • 腫瘤學
    • 2018-2030 年腫瘤學市場估計與預測
  • 心臟病學
    • 2018-2030 年心臟病市場估計與預測
  • 腎臟病學
    • 2018-2030 年腎臟疾病市場估計與預測
  • 自體免疫疾病
    • 2018-2030 年自體免疫疾病市場估計與預測
  • 藥檢
    • 2018-2030 年藥物檢測市場估計與預測
  • 血液疾病
    • 2018-2030 年血液疾病市場估計與預測
  • 其他
    • 2018-2030 年其他市場估計與預測

第8章美國IVD 市場：區域細分分析，2018-2030

  • 區域分析 –美國IVD 市場
    • 美國IVD市場趨勢
    • 主要國家趨勢
    • 美國的危險因子和主要慢性病
    • 競爭場景
    • 法律規範
    • 贖回場景
    • 2018-2030 年美國IVD 市場估計與預測

第9章競爭分析

  • 參與企業
    • BD
    • 伯樂實驗室有限公司
    • 方丈
    • 安捷倫科技有限公司
    • 西門子醫療保健有限公司
    • 凱傑
    • 生物梅里埃
    • 奎德爾有限公司
    • 霍夫曼羅氏有限公司
  • 參與企業概況
  • 財務績效
  • 產品基準評效
  • 2023 年公司市場佔有率分析
  • 策略規劃
    • 擴張
    • 獲得
    • 產品/服務發布
    • 其他

第10章分析師的觀點

Product Code: GVR-4-68039-256-6

U.S. In Vitro Diagnostics Market Growth & Trends:

The U.S. in vitro diagnostics market size is expected to reach USD 37.58 billion by 2030, according to a new report by Grand View Research, Inc. The market is anticipated to grow at a CAGR of 3.70% from 2024 to 2030. Medical instruments that perform diagnostic tests on bio-fluids including blood, urine, and tissues are known as in vitro diagnostics (IVD). The IVD tests are used to study pharmacological therapy and to identify and evaluate infectious diseases, autoimmune disorders, and a variety of medical ailments.

The rising prevalence of chronic and pathogenic diseases, the aging population, the increasing popularity of point-of-care testing, and personalized medicine are anticipated to increase the demand for IVD testing in the country. Moreover, with developments in genomics & proteomics, this industry is seeing new prospects as molecular diagnostics expands its reach and introduces a new variety of condition-specific indicators and tests.

Several ailments, such as genetic, cardiovascular, and neurological disorders, are becoming more common. Cardiovascular diseases (CVDs) are the major cause of death in the U.S., killing an estimated 659,000 people each year, as per the Centers for Disease Control and Prevention (CDC). This has resulted in a significant public awareness about early diagnosis and a rise in routine diagnosis, both of which support the market's overall development.

The launch of new advanced IVD products is assisting the market's rapid expansion. Moreover, market players and research institutes are actively involved in the development of novel products to reduce the overall disease burden in the country. For instance, in May 2021, the University of California developed an ultrasensitive molecular test. This test is based on a chip technology that can detect the presence of influenza A and SARS-CoV-2 antigens. The test is under further study for conversion into a Point-of-Care (PoC) test.

The adoption of IVD testing at the point-of-care testing facilities is increasing rapidly. As several players are focusing on launching tests for home care facilities, there has been a shift in the industry dynamics. Moreover, in 2021, FDA also prioritized home-based molecular diagnostics tests. In March 2021, BATM Advanced Communications Limited announced the launch of its molecular diagnostics self-test kit for the detection of COVID-19.

The market is gaining strength as diagnostic laboratories increasingly employ fully automated tools. Automated instruments, as opposed to manual and semi-automated equipment, are more expandable, meet high level of performance, reduce technologists' hands-on time, eliminate batch testing, and provide faster results to physicians. Market participants are increasingly working on building automated instruments as a result of these benefits.

Furthermore, laboratory automation facilitates, expedites, and improves the efficiency and efficacy of diagnostic tests. From loading specimen tubes to providing findings for all major laboratory disciplines, a total lab automated system can handle all parts of the testing process. As more manufacturers enter the market with broader automation choices, the evolution of lab automation in the clinical diagnostics business is continuing to accelerate.

Since it is utilized to detect the SARS-CoV-2 virus, the COVID-19 pandemic has increased the demand for molecular diagnostics tools. Additionally, among hospitalized patients suffering from COVID-19, there was a surge in demand for test kits and consumables for measuring blood glucose levels, troponin levels, and a variety of other parameters. As a result, the usage of IVD devices increased during the pandemic and propelled the market growth.

U.S. In Vitro Diagnostics Market Report Highlights:

  • By product, the reagent segment held a larger share of the U.S. IVD market owing to the increasing demand for genetic testing and the availability of advanced cancer diagnostic tests in the country
  • The coagulation segment is expected to be the fastest-growing segment. The rising prevalence of cardiovascular diseases, blood-related disorders, and autoimmune diseases is expected to boost the demand for coagulation testing
  • The oncology segment is anticipated to grow at the fastest CAGR over the forecast period owing to the increasing prevalence of disease and increasing awareness among people about early diagnosis of diseases
  • A few of the key market players include QIAGEN; F. Hoffman-La Roche Ltd.; Thermo Fisher Scientific, Inc.; Danaher Corporation; Illumina

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Market Segmentation And Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database:
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
  • 1.7 Research Assumptions
  • 1.8 List Of Secondary Sources
  • 1.9 List Of Abbreviations
  • 1.10 Objectives
    • 1.10.1 Objective 1
    • 1.10.2 Objective 2
    • 1.10.3 Objective 3
    • 1.10.4 Objective 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Segment Snapshot
  • 2.4 Competitive Landscape Snapshot

Chapter 3 U.S. IVD Market Variables, Trends, & Scope

  • 3.1 IVD Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
  • 3.2 Regulatory Framework
  • 3.3 Market Driver Analysis
    • 3.3.1 Growing Geriatric Population
    • 3.3.2 Technological Advancements
    • 3.3.3 Increasing Demand For Poc Facilities
    • 3.3.4 Growing Prevalence Of Target Diseases Such As Genetic, Cardiovascular, & Neurological Diseases And Hospital-Acquired Infections
    • 3.3.5 Outbreak Of Covid-19
  • 3.4 Market Restraint Analysis
    • 3.4.1 Higher Cost Of Devices
    • 3.4.2 Stringent Regulatory Policies
  • 3.5 Value Chain Analysis
    • 3.5.1 Value Chain Analysis/Route To Market
  • 3.6 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
  • 3.7 Porter's Five Forces Analysis

Chapter 4 U.S. IVD Market - Segment Analysis, By Product, 2018 - 2030 (USD Million)

  • 4.1 U.S. In Vitro Diagnostic Market: Products Movement Analysis
  • 4.2 Instruments
    • 4.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Reagents
    • 4.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.4 Services
    • 4.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 U.S. IVD Market-Segment Analysis, By Technology, 2018 - 2030 (USD Million)

  • 5.1 In Vitro Diagnostics Market: Technology Movement Analysis
  • 5.2 Immunoassay
    • 5.2.1 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.2 Instruments
      • 5.2.2.1 Instruments Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.3 Reagents
      • 5.2.3.1 Reagents Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.2.4 Services
      • 5.2.4.1 Services Market For Immunoassay Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Hematology
    • 5.3.1 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.2 Instruments
      • 5.3.2.1 Instruments Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.3 Reagents
      • 5.3.3.1 Reagents Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.4 Services
      • 5.3.4.1 Services Market For Hematology Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Clinical Chemistry
    • 5.4.1 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.2 Instruments
      • 5.4.2.1 Instruments Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.3 Reagents
      • 5.4.3.1 Reagents Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.4.4 Services
      • 5.4.4.1 Services Market For Clinical Chemistry Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 Molecular Diagnostics
    • 5.5.1 Moecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.2 Instruments
      • 5.5.2.1 Instruments Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.3 Reagents
      • 5.5.3.1 Reagents Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.5.4 Services
      • 5.5.4.1 Services Market For Molecular Diagnostics Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 Coagulation
    • 5.6.1 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.6.2 Instruments
      • 5.6.2.1 Instruments Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.6.3 Reagents
      • 5.6.3.1 Reagents Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.6.4 Services
      • 5.6.4.1 Services Market For Coagulation Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.7 Microbiology
    • 5.7.1 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.7.2 Instruments
      • 5.7.2.1 Instruments Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.7.3 Reagents
      • 5.7.3.1 Reagents Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.7.4 Services
      • 5.7.4.1 Services Market For Microbiology Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.8 Others
    • 5.8.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.2 Instruments
      • 5.8.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.3 Reagents
      • 5.8.3.1 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.8.4 Services
      • 5.8.4.1 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 U.S. IVD Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 6.1 In Vitro Diagnostic Market: End-Use Movement Analysis
  • 6.2 Hospitals
    • 6.2.1 Hospitals Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Hospitals Market, By Technology
      • 6.2.2.1 Immunoassay
      • 6.2.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.3 Hematology
      • 6.2.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.5 Clinical Chemistry
      • 6.2.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.7 Molecular Diagnostics
      • 6.2.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.9 Coagulation
      • 6.2.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.11 Microbiology
      • 6.2.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.13 Others
      • 6.2.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Laboratory
    • 6.3.1 Laboratory Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2 Laboratory Market, By Technology
      • 6.3.2.1 Immunoassay
      • 6.3.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.3 Hematology
      • 6.3.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.5 Clinical Chemistry
      • 6.3.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.7 Molecular Diagnostics
      • 6.3.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.9 Coagulation
      • 6.3.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.11 Microbiology
      • 6.3.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.13 Others
      • 6.3.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.3.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Home Care
    • 6.4.1 Home Care Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2 Home Care Market, By Technology
      • 6.4.2.1 Immunoassay
      • 6.4.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.3 Hematology
      • 6.4.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.5 Clinical Chemistry
      • 6.4.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.7 Molecular Diagnostics
      • 6.4.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.9 Coagulation
      • 6.4.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.11 Microbiology
      • 6.4.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.13 Others
      • 6.4.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.5 Others
    • 6.5.1 Other Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.5.2 Others Market, By Technology
      • 6.5.2.1 Immunoassay
      • 6.5.2.2 Immunoassay Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.2.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.2.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.2.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.3 Hematology
      • 6.5.2.4 Hematology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.4.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.4.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.4.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.5 Clinical Chemistry
      • 6.5.2.6 Clinical Chemistry Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.6.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.6.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.6.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.7 Molecular Diagnostics
      • 6.5.2.8 Molecular Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.8.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.8.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.8.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.9 Coagulation
      • 6.5.2.10 Coagulation Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.10.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.10.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.10.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.11 Microbiology
      • 6.5.2.12 Microbiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.12.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.12.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.12.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.13 Others
      • 6.5.2.14 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.14.1 Instruments Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.14.2 Reagents Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.5.2.14.3 Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 U.S. IVD Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 7.1 U.S. In Vitro Diagnostics Market: Application Movement Analysis
  • 7.2 Infectious Diseases
    • 7.2.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.1 Upper Respiratory
      • 7.2.1.1.1 Upper Respiratory Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.2 Gastrointestinal Panel Testing
      • 7.2.1.2.1 Gastrointestinal Panel Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.3 Methicillin-Resistant Staphylococcus Aureus (MRSA)
      • 7.2.1.3.1 MRSA Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.4 Clostridium Difficile
      • 7.2.1.4.1 Clostridium Difficile Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.5 Vancomycin-Resistant Enterococci (VRE)
      • 7.2.1.5.1 VRE Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.6 Carbapenem-Resistant Bacteria
      • 7.2.1.6.1 Carbapenem-Resistant Bacteria Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.7 Flu
      • 7.2.1.7.1 Flu Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.8 Respiratory Syncytial Virus (RSV)
      • 7.2.1.8.1 RSV Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.9 Candida
      • 7.2.1.9.1 Candida Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.10 Tuberculosis (TB) And Drug-Resistant TB
      • 7.2.1.10.1 TB And Drug-Resistant TB Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.11 Meningitis
      • 7.2.1.11.1 Meningitis Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.12 Chlamydia
      • 7.2.1.12.1 Chlamydia Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.13 Gonorrhoea
      • 7.2.1.13.1 Gonorrhoea Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.14 HIV
      • 7.2.1.14.1 HIV Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.15 Hepatitis C
      • 7.2.1.15.1 Hepatitis C Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.16 Hepatitis B
      • 7.2.1.16.1 Hepatitis B Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.17 Other Infectious Diseases
      • 7.2.1.17.1 Other Infectious Disease Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Diabetes
    • 7.3.1 Diabetes Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Oncology
    • 7.4.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.5 Cardiology
    • 7.5.1 Cardiology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.6 Nephrology
    • 7.6.1 Nephrology Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.7 Autoimmune Diseases
    • 7.7.1 Autoimmune Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.8 Drug Testing
    • 7.8.1 Drug Testing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.9 Hematologic Diseases
    • 7.9.1 Hematologic Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.10 Others
    • 7.10.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 U.S. IVD Market: Segment Analysis, By Region, 2018 - 2030 (USD Million)

  • 8.1 Regional Analysis - The U.S. IVD Market
    • 8.1.1 Trends In The U.S. IVD Market
    • 8.1.2 Key Country Dynamics
    • 8.1.3 Risk Factors And Major Chronic Diseases In The U.S.
    • 8.1.4 Competitive Scenario
    • 8.1.5 Regulatory Framework
    • 8.1.6 Reimbursement Scenario
    • 8.1.7 U.S. IVD Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Competitive Analysis

  • 9.1. Participant Categorization
    • 9.1.1. BD
      • 9.1.1.1. Overview
      • 9.1.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.1.3. Product Benchmarking
      • 9.1.1.4. Strategic Initiatives
    • 9.1.2. Bio-Rad Laboratories, Inc.
      • 9.1.2.1. Overview
      • 9.1.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.2.3. Product Benchmarking
      • 9.1.2.4. Strategic Initiatives
    • 9.1.3. Abbott
      • 9.1.3.1. Overview
      • 9.1.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.3.3. Product Benchmarking
      • 9.1.3.4. Strategic Initiatives
    • 9.1.4. Agilent Technologies, Inc.
      • 9.1.4.1. Overview
      • 9.1.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.4.3. Product Benchmarking
      • 9.1.4.4. Strategic Initiatives
    • 9.1.5. Siemens Healthcare GmbH
      • 9.1.5.1. Overview
      • 9.1.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.5.3. Product Benchmarking
      • 9.1.5.4. Strategic Initiatives
    • 9.1.6. Qiagen
      • 9.1.6.1. Overview
      • 9.1.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.6.3. Product Benchmarking
      • 9.1.6.4. Strategic Initiatives
    • 9.1.7. bioMerieux
      • 9.1.7.1. Overview
      • 9.1.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.7.3. Product Benchmarking
      • 9.1.7.4. Strategic Initiatives
    • 9.1.8. Quidel Corporation
      • 9.1.8.1. Overview
      • 9.1.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.8.3. Product Benchmarking
      • 9.1.8.4. Strategic Initiatives
    • 9.1.9. F. Hoffmann-La Roche, Ltd.
      • 9.1.9.1. Overview
      • 9.1.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
      • 9.1.9.3. Product Benchmarking
      • 9.1.9.4. Strategic Initiatives
  • 9.2. Participant's Overview
  • 9.3. Financial Performance
  • 9.4. Product Benchmarking
  • 9.5. Company Market Share Analysis, 2023
  • 9.6. Strategy Mapping
    • 9.6.1. Expansion
    • 9.6.2. Acquisition
    • 9.6.3. Product/Service Launch
    • 9.6.4. Others

Chapter 10. Analyst View  

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Regulatory framework
  • Table 4 Current oversight of diagnostic tests
  • Table 5 EUA IVD tests for COVID-19 in March and April 2020 (Early Entrants)
  • Table 6 List of FDA approved immunoassays during early stage of pandemic
  • Table 7 List of key distributors
  • Table 8 List of key emerging companies/technology disruptors/innovators
  • Table 9 U.S. in vitro diagnostics market, by product, 2018 - 2030 (USD Million) (Volume, number of instruments and tests)
  • Table 10 U.S. in vitro diagnostics market, by technology, 2018 - 2030 (USD Million) (Volume, number of instruments and tests)
  • Table 11 U.S. in vitro diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 12 U.S. in vitro diagnostics market, by end-use, 2018 - 2030 (USD Million) (Volume, number of instruments and tests)

List of Figures

  • Fig. 1 U.S. in vitro diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. in vitro diagnostics market outlook (2023)
  • Fig. 10 Parent market outlook, 2023
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Taking control of the changing regulatory landscape
  • Fig. 13 In vitro diagnostic market driver impact
  • Fig. 14 Geriatric population in the U.S.
  • Fig. 15 In vitro diagnostics market restraint impact
  • Fig. 16 Market entry strategy
  • Fig. 17 SWOT analysis, by factor (political & legal, economic, and technological)
  • Fig. 18 Porter's five forces analysis
  • Fig. 19 Strategy mapping
  • Fig. 20 U.S. in vitro diagnostics market: Product outlook and key takeaways
  • Fig. 21 U.S. in vitro diagnostics market: Products movement analysis
  • Fig. 22 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 23 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 24 Services market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. in vitro diagnostics market: Technology outlook and key takeaways
  • Fig. 26 U.S. in vitro diagnostics market: Technology movement analysis
  • Fig. 27 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Instruments market for immunoassay estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 29 Reagents market for immunoassay estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 30 Services market for immunoassay estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 32 Instruments market for hematology estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 33 Reagents market for hematology estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 34 Services market for hematology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Instruments market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 37 Reagents market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 38 Services market for clinical chemistry estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 39 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 Instruments market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 41 Reagents market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 42 Services market for molecular diagnostics estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 43 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 44 Instruments market for coagulation estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 45 Reagents market for coagulation estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 46 Services market for coagulation estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 47 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 48 Instruments market for microbiology estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 49 Reagents market for microbiology estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 50 Services market for microbiology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 51 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 52 Instruments others market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 53 Reagents others market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 54 Services market for other technology estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 55 U.S. in vitro diagnostics market: End-use outlook and key takeaways
  • Fig. 56 U.S. in vitro diagnostics market: End-use movement analysis
  • Fig. 57 Hospitals market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 58 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 59 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 60 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 61 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 62 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 63 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 64 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 65 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 66 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 67 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 68 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 69 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 70 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 71 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 72 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 73 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 74 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 76 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 77 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 78 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 80 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 81 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 82 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 84 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 85 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Laboratory market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 87 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 88 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 89 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 90 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 91 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 92 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 93 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 94 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 95 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 96 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 97 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 98 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 99 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 100 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 101 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 102 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 103 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 104 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 105 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 106 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 107 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 108 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 109 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 110 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 111 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 112 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 113 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 114 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 115 Home care market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 116 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 117 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 118 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 119 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 120 Hematology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 121 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 122 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 123 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 124 Clinical chemistry market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 125 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 126 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 127 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 128 Molecular diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 129 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 130 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 131 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 132 Coagulation market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 133 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 134 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 135 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 136 Microbiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 137 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 138 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 139 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 140 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 141 Instruments market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of instruments)
  • Fig. 142 Reagents market estimates and forecast, 2018 - 2030 (USD Million) (volume, number of tests)
  • Fig. 143 Immunoassay market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 144 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 145 U.S. in vitro diagnostics market: Application outlook and key takeaways
  • Fig. 146 U.S. in vitro diagnostics market: Application movement analysis
  • Fig. 147 Infectious diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 148 Upper respiratory market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 149 Gastrointestinal panel testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 150 MRSA market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 151 Clostridium difficile market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 152 VRE market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 153 Carbapenem-resistant bacteria market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 154 Flu market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 155 RSV market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 156 Candida market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 157 TB and drug-resistant TB market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 158 Meningitis cancer market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 159 Chlamydia market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 160 Gonorrhea market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 161 HIV market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 162 Hepatitis C market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 163 Hepatitis B market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 164 Other infectious disease market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 165 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 166 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 167 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 168 Nephrology market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 169 Autoimmune diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 170 Drug testing market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 171 Hematologic diseases market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 172 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 173 U.S. in vitro diagnostics market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 174 Competition categorization
  • Fig. 175 Company market share analysis, 2023